Axillary Apocrine Carcinoma Associated with Apocrine Adenoma and Apocrine Gland Hyperplasia by Tatjana Bujas et al.
148
Acta Dermatovenerol Croat                  2007;15(3):148-151                           CASE REPORT
Axillary Apocrine Carcinoma Associated with Apocrine 
Adenoma and Apocrine Gland Hyperplasia
Tatjana Bujas1, Ivana Pavić2, Tanja Leniček2, August Mijić3, Božo Krušlin2, Davor 
Tomas2
1Department of Pathology, Karlovac General Hospital, Karlovac; 2Ljudevit Jurak 
Department of Pathology; 3University Department of Surgery, Sestre milosrdnice 
University Hospital, Zagreb, Croatia
Corresponding author:
Davor Tomas, MD, PhD
Ljudevit Jurak Department of Pathology





Received: January 30, 2007
Accepted: July 10, 2007
SUMMARY Apocrine carcinomas represent a rare group of tumors 
with a potential for destructive local invasion, regional and distant 
metastases, and are equally common in both sexes. A case of a 79-
year-old woman with axillary apocrine carcinoma associated with 
apocrine adenoma and apocrine gland hyperplasia is presented. To 
our knowledge, this is the first case diagnosed in a Caucasian and 
also the first case diagnosed in a female patient. Grossly, the tumor 
measured 3.2x1.5x1.2 cm and on cut section appeared granular, 
white to gray-tanned. Microscopically, the tumor was located in the 
dermis, poorly demarcated, focally necrotic with ulcerated overlying 
skin. It was predominantly composed of complex, closely packed 
tubuloglandular structures but in few areas papillary structures were 
also observed. The cells contained abundant eosinophilic, finely 
granular cytoplasm with pleomorphic nuclei and showed apocrine-like 
decapitation. The cytoplasm contained periodic acid Schiff diastase 
resistant granules. Mitoses were frequent and some were atypical. In 
one area, the tumor was lobular and composed of tubular structures 
lined with one layer of uniform cuboidal or columnar eosinophilic 
cells, indicating a pre-existing apocrine adenoma. Beneath the tumor, 
in the deep dermis and subcutaneous tissue, hyperplastic apocrine 
glands were also found. No additional therapy was used, and one year 
after the surgery the patient was alive and showed no signs of tumor 
spread. This and previously reported cases suggest that apocrine 
hyperplasia and apocrine adenoma may represent successive steps 
in the development of apocrine carcinoma.
KeY woRdS: apocrine carcinoma, apocrine adenoma, apocrine 
glands hyperplasia
INTRodUCTIoN
Apocrine carcinomas represent a rare group 
of tumors with a potential for destructive local in-
vasion, regional and distant metastases. The dis-
ease is primarily diagnosed in the fifth to seventh 
decade of life, with similar incidence in men and 
women and without racial predilection (1-4). Apo-
crine carcinoma shows features of apocrine dif-
ferentiation and most frequently arises in regions 
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of high apocrine gland density, especially in the 
axilla. Rarely, it may also arise in the eyelids (origi-
nating from Moll’s glands), upper outer aspect of 
the breast, perianal region and upper arm where 
apocrine glands are greatest in number (3,4).
The etiology of apocrine carcinoma is unknown. 
The fact that all patients were over 25 years sug-
gests that full maturity of the apocrine glands is a 
prerequisite (2).  
Herein, we present a case of a 79-year-old 
woman with axillary apocrine carcinoma associ-
ated with apocrine adenoma and apocrine gland 
hyperplasia.
CASe RePoRT
A 79-year-old woman was admitted because 
of a painless tumor in her left axilla. The tumor 
had slowly enlarged during the past six months. 
Physical examination revealed a soft, pink, dome 
shaped tumor, about 3 cm in diameter, which ad-
hered to the overlying skin and was centrally ul-
cerated. The cervical, supraclavicular and axillary 
lymph nodes were without signs of tumor spread. 
There were no palpable abnormalities of the left 
breast. Additional studies (ultrasonography and 
chest x-ray) revealed no primary breast tumor or 
metastatic disease.
The tumor was radically excised and submit-
ted to pathology. Grossly, the tumor measured 
3.2x1.5x1.2 cm and on cut section appeared gran-
ular, white to gray-tanned. Microscopically, the tu-
mor was located in the dermis, poorly demarcated, 
focally necrotic and the overlying skin was ulcer-
ated. It was predominantly composed of complex, 
closely packed tubuloglandular structures but in 
few areas papillary structures were also observed 
(Fig. 1A). The cells contained abundant eosino-
philic, finely granular cytoplasm with pleomorphic 
nuclei and showed apocrine-like decapitation. The 
cytoplasm contained periodic acid Schiff diastase 
resistant granules. Mitoses were frequent (up to 
15 mitoses per 10 high power fields) and some 
were atypical. In one area, the tumor was lobular 
and composed of tubular structures lined with one 
layer of uniform cuboidal or columnar eosinophilic 
cells, indicating a pre-existing apocrine adenoma 
(Fig. 1B). Beneath the tumor, in the deep dermis 
and subcutaneous tissue, hyperplastic apocrine 
glands were observed (Fig. 1C). Immunohisto-
chemically, tumor cells were positive for cytokera-
tin and epithelial membrane antigen while carcino-
embryonic antigen and S-100 protein were nega-
tive. In carcinomatous areas alpha smooth muscle 
actin was negative (Fig. 1D), while in adenoma-
tous (Fig. 1E) and hyperplastic regions (Fig. 1F) 
positivity around tubules indicated the presence of 
myoepithelial cell layer. Adenocarcinomatous and 
adenomatous cells were negative for estrogen 
and progesterone receptors and HER2-neu. Ki67 
and p53 positivity was 27.3% and 43.2% in ad-
enocarcinoma, and 4.3% and 52.6% in adenoma, 
respectively. 
No additional therapy was administered, and 
one year after the surgery the patient was alive 
and showed no signs of tumor spread.
dISCUSSIoN
Apocrine carcinomas are rare tumors which 
equally affect both sexes, but to our knowledge, 
this is the first case of axillary apocrine carcinoma 
associated with apocrine adenoma and apocrine 
glands hyperplasia diagnosed in a Caucasian and 
also the first case diagnosed in a female patient.
Apocrine carcinoma usually grows slowly and 
presents as painless, solitary or multiple, solid or 
cystic mass, ranging from 1 to over 8 cm in size 
(1,2). These lesions tend to vary in color from red 
to purple, and show ulceration of the overlying 
skin. There are no distinctive physical findings that 
would allow a clinician to suspect the diagnosis 
of apocrine carcinoma and most of them exist for 
less than one year before a correct diagnosis is 
made (3-5). Therefore, up to 50% of apocrine car-
cinomas have synchronous lymph node metasta-
ses at the time of diagnosis. Metastatic disease to 
the lung, skin, bone, brain, and kidney has been 
described and the disease is invariably fatal at this 
stage (3,4).
Histologically, apocrine carcinomas are non-
encapsulated, infiltrative tumors located in the 
lower dermis and subcutaneous tissue, and con-
sist of multiple ductal structures. Different growth 
patterns include papillary, tubular, cribriform, cord-
like and solid. Tumor cells are eosinophilic with 
granular and sometimes vacuolated cytoplasm 
and contain periodic acid Schiff positive, diastase 
resistant granules (1). A key diagnostic crite-
rion, decapitation secretion in the form of apical 
snouts, is usually recognizable but may be lacking 
in poorly differentiated tumors (2). Mitotic activity 
is variable, ranging from single mitotic figures in 
well differentiated tumors to up to 4 mitotic figures 
per high power field. Immunohistochemically, tu-
mor cells usually express cytokeratin, epithelial 
membrane antigen and gross cystic disease fluid 
protein-15. Carcinoembryonic antigen is usually 
negative. Some cases demonstrate positivity for 
S100 protein (1-4). 
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Figure 1. (A) The tumor was predominantly composed of complex, closely packed tubulo-glandular struc-
tures. The cells contained abundant eosinophilic, finely granular cytoplasm with pleomorphic nuclei and 
showed apocrine-like decapitation (X200, HE); (B) in one area, the tumor was lobular and composed of 
tubular structures lined with one layer of uniform cuboidal or columnar eosinophilic cells, indicating a pre-
existing apocrine adenoma (X200, HE); (C) beneath the tumor, in the deep dermis and subcutaneous tis-
sue, hyperplastic apocrine glands were observed (X200, HE); (D) in carcinomatous areas alpha smooth 
muscle actin was negative (X200, α-SMA), while in adenomatous (E) (X200, α-SMA) and hyperplastic (F) 
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The main differential diagnosis is apocrine ad-
enoma, and histologic features that distinguish 
the two conditions are often subtle (1,2). Necrosis, 
infiltrative growth pattern, cellular pleomorphism 
and loss of myoepithelial cells, which is readily 
demonstrable with immunohistochemical staining 
for alpha smooth muscle actin or calponin, may 
provide a clue to malignancy (1-5).
In our case, the tumor was obviously malignant 
(pleomorphism, high mitotic rate, necrosis, infiltra-
tive growth pattern, loss of myoepithelial cells) but 
in one area the tumor was lobular and composed 
of tubular structures lined with one layer of uniform 
eosinophilic cells, with preserved myoepithelial 
cells that were immunohistochemically positive for 
alpha smooth muscle actin. These findings indi-
cate a pre-existing apocrine adenoma in apocrine 
carcnoma. In the deep dermis and subcutaneous 
tissue, hyperplastic apocrine glands were also 
found and the diagnosis of apocrine carcinoma 
with associated apocrine adenoma and apocrine 
gland hyperplasia was established.
Wide, local excision with complete removal of 
the tumor is the standard treatment for these le-
sions. Therapeutic lymph node dissection is indi-
cated for confirmed lymph node metastases and 
may have a role in a setting of large or highly 
aggressive tumor. Apocrine carcinoma poorly re-
sponds to chemotherapy but adjuvant radiother-
apy may have a role in a setting of advanced or 
disseminated disease (3,4). 
Only five cases of coexistence of malignant 
and benign apocrine tumors in the axilla have 
been reported (5-9). All these patients were el-
derly Japanese men and some speculations, like 
in cases of triple extramammary Paget’s disease 
(10), that androgens or some environmental fac-
tors might play a role in the pathogenesis of these 
tumors, have been proposed (5). In our case, the 
patient was a Caucasian and a female. This and 
previously reported cases (5-9) suggest that in 
certain cases apocrine hyperplasia and apocrine 
adenoma represent successive steps in the devel-
opment of apocrine carcinoma.
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